Latest News and Press Releases
Want to stay updated on the latest news?
-
PRESS RELEASE Poster presentation at EASL by Dr. Florence Wong on 21 June 2023; selected for additional poster presentation on 23 June 2023Conference call with live webcast by Sequana Medical on 21...
-
Ghent, Belgium – 16 June 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and...
-
PRESS RELEASEREGULATED INFORMATION26 May 2023, 07:00 am CEST Ghent, Belgium – 26 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
-
PRESS RELEASEREGULATED INFORMATION25 May 2023, 06:00 pm CEST Ghent, Belgium – 25 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
-
PRESS RELEASEREGULATED INFORMATION 15 May 2023, 06:00 pm CEST Ghent, Belgium – 15 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
-
PRESS RELEASEREGULATED INFORMATION10 May 2023, 06:00 p.m. CEST Ghent, Belgium, 10 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
-
PRESS RELEASE MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end Randomized, controlled study in US seeking to confirm strong efficacy data seen in RED DESERT and...
-
PRESS RELEASEREGULATED INFORMATION27 April 2023, 07:00 p.m. CEST Ghent, Belgium, 27 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
-
PRESS RELEASEREGULATED INFORMATION25 April 2023, 07:00 am CEST Publication of Annual Report 2022 Ghent, Belgium – 25 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or...
-
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...